Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 21;8(1):00551-2021.
doi: 10.1183/23120541.00551-2021. eCollection 2022 Jan.

Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan

Affiliations

Treatment outcomes among childhood extensively drug-resistant tuberculosis patients in Pakistan

Muhammad Abubakar et al. ERJ Open Res. .

Abstract

Treatment outcomes of childhood XDR-TB patients in Pakistan are better than in adult patients but still disappointing https://bit.ly/3rkQ9sw.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

References

    1. World Health Organization . WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva, World Health Organization, 2019. - PubMed
    1. World Health Organization . WHO announces updated definitions of extensively drug-resistant tuberculosis. www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-ex... Date last updated: 27 January 2021.
    1. Abubakar M, Ahmad N, Ghafoor A, et al. . Treatment outcomes of extensively drug-resistant tuberculosis in Pakistan: a countrywide retrospective record review. Front Pharmacol 2021; 12: 499. - PMC - PubMed
    1. Osman M, Harausz EP, Garcia-Prats AJ, et al. . Treatment outcomes in global systematic review and patient meta-analysis of children with extensively drug-resistant tuberculosis. Emerg Infect Dis 2019; 25: 441–450. doi:10.3201/eid2503.180852 - DOI - PMC - PubMed
    1. Solodovnikova V, Kumar AM, Hurevich H, et al. . Effectiveness and safety of delamanid-or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: a nationwide study from Belarus, 2015–19. Monaldi Arch Chest Dis 2021; 91: 1646. doi:10.4081/monaldi.2021.1646 - DOI - PubMed

LinkOut - more resources